Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse- human transporter

doi:10.1084/jem.177.6.1785

This Article

	Full Text (PDF)
	Alert me when this article is cited

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Yewdell, J. W.
	Articles by Bennink, J. R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Yewdell, J. W.
	Articles by Bennink, J. R.


Social Bookmarking

	What's this?

ARTICLES

Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse- human transporter

JW Yewdell, F Esquivel, D Arnold, T Spies, LC Eisenlohr and JR Bennink
Laboratory of Viral Diseases, National Institute of Allergy and Infections Diseases, National Institutes of Health, Bethesda, Maryland 20892.

The major histocompatibility complex-encoded transporter associated with antigen processing (TAP) is required for the efficient presentation of cytosolic antigens to class I-restricted T cells. TAP is thought to be formed by the interaction of two gene products, termed TAP1 and TAP2. We find that TAPs consisting either of human subunits, or mouse TAP1 and human TAP2, facilitate the presentation of numerous defined viral peptides to mouse class I-restricted T cells. As human and mouse TAP2 and TAP1 differ in 23 and 28% of their residues, respectively, this indicates that TAP1 and TAP2 can form a functional complex with partners considerably different from those they coevolved with. Moreover, these findings indicate that widely disparate TAPs facilitate delivery of the same peptides to class I molecules. These findings suggest that TAP polymorphism does not greatly influence the types of peptides presented to the immune system.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Zhu, X., Peng, J., Chen, D., Liu, X., Ye, L., Iijima, H., Kadavil, K., Lencer, W. I., Blumberg, R. S. (2005). Calnexin and ERp57 Facilitate the Assembly of the Neonatal Fc Receptor for IgG with {beta}2-Microglobulin in the Endoplasmic Reticulum. J. Immunol. 175: 967-976 [Abstract] [Full Text]
Ritz, U., Drexler, I., Sutter, D., Abele, R., Huber, C., Seliger, B. (2003). Impaired Transporter Associated with Antigen Processing (TAP) Function Attributable to a Single Amino Acid Alteration in the Peptide TAP Subunit TAP1. J. Immunol. 170: 941-946 [Abstract] [Full Text]
Fu, T.-M., Mylin, L. M., Schell, T. D., Bacik, I., Russ, G., Yewdell, J. W., Bennink, J. R., Tevethia, S. S. (1998). An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40�Large T Antigen Cytotoxic T-Lymphocyte Epitope. J. Virol. 72: 1469-1481 [Abstract] [Full Text]